Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SGMT market cap is 104.14M. The company's latest EPS is USD and P/E is N/A.
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 2M |
| Operating Income | -23.72M | -31.06M | -30.74M |
| Net Income | -24.44M | -30.5M | -27.88M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.03M | 33.03M | 96.72M |
| Total Liabilities | 2.67M | 5.36M | 5.65M |
| Total Equity | -158.26M | -186.95M | 91.07M |
| Market Cap | 104.14M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 30.67M |
| Average Volume (1 week) | 362.14k |
| Average Volume (1 Month) | 580.15k |
| 52 Week Change | -41.57% |
| 52 Week High | 7.38 |
| 52 Week Low | 2.39 |
| Spread (Intraday) | 0.05 (1.45%) |
| Company Name | Sagiment Biosciences Inc |
| Address |
2140 south dupont highway camden, delaware 19934 |
| Website | https://www.sagimet.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
